Bruce Leuchter, M.D.

Bruce Leuchter, M.D. has a diverse work experience in the healthcare industry. Bruce is currently serving as the President & CEO of Neurvati Neurosciences, a company that focuses on developing technologies to address neurological and psychiatric disorders. Prior to that, they co-founded Click Therapeutics, Inc. and worked as a Senior Advisor, working on digital therapeutics for individuals with brain disorders.

Bruce Leuchter has also held positions at PJT Partners and Credit Suisse, where they advised healthcare clients on corporate strategy, M&A transactions, and financings. Bruce previously worked at Weill Cornell Medical College as the Director of Clinical Neuropsychiatry and as an Assistant Professor of Psychiatry, focusing on the comprehensive management of various mental disorders. Additionally, they were a Biotechnology Analyst at Goldman Sachs, where they researched emerging biotechnology drugs, devices, and diagnostics.

In the beginning of their career, Bruce Leuchter worked at New York Presbyterian Hospital as an Attending Psychiatrist, Psychiatry Resident, and Neurology Resident.

Bruce Leuchter, M.D. completed their Bachelor of Arts (B.A.) degree with High Distinction and Honors in Studies in Religion at the University of Michigan from 1992 to 1996. Bruce then attended Wayne State University School of Medicine, where they earned their Medical Doctor (M.D.) degree in Medicine from 1996 to 2000.

In addition to their medical education, Dr. Leuchter has acquired additional certifications. In May 2007, they obtained certification from the American Board of Psychiatry and Neurology. Bruce also holds several financial industry certifications, including Series 7, 63, 86, 87, 79, and 24, which were obtained from the Financial Industry Regulatory Authority (FINRA). The specific details of the institution where they obtained their financial certifications are not provided.